Genetically modulated educational attainment and coronary disease risk.


Journal

European heart journal
ISSN: 1522-9645
Titre abrégé: Eur Heart J
Pays: England
ID NLM: 8006263

Informations de publication

Date de publication:
01 08 2019
Historique:
received: 04 07 2017
revised: 30 08 2017
accepted: 03 05 2019
pubmed: 7 6 2019
medline: 12 9 2020
entrez: 7 6 2019
Statut: ppublish

Résumé

Genetic disposition and lifestyle factors are understood as independent components underlying the risk of multiple diseases. In this study, we aim to investigate the interplay between genetics, educational attainment-an important denominator of lifestyle-and coronary artery disease (CAD) risk. Based on the effect sizes of 74 genetic variants associated with educational attainment, we calculated a 'genetic education score' in 13 080 cases and 14 471 controls and observed an inverse correlation between the score and risk of CAD [P = 1.52 × 10-8; odds ratio (OR) 0.79, 95% confidence interval (CI) 0.73-0.85 for the higher compared with the lowest score quintile]. We replicated in 146 514 individuals from UK Biobank (P = 1.85 × 10-6) and also found strong associations between the 'genetic education score' with 'modifiable' risk factors including smoking (P = 5.36 × 10-23), body mass index (BMI) (P = 1.66 × 10-30), and hypertension (P = 3.86 × 10-8). Interestingly, these associations were only modestly attenuated by adjustment for years spent in school. In contrast, a model adjusting for BMI and smoking abolished the association signal between the 'genetic education score' and CAD risk suggesting an intermediary role of these two risk factors. Mendelian randomization analyses performed with summary statistics from large genome-wide meta-analyses and sensitivity analysis using 1271 variants affecting educational attainment (OR 0.68 for the higher compared with the lowest score quintile; 95% CI 0.63-0.74; P = 3.99 × 10-21) further strengthened these findings. Genetic variants known to affect educational attainment may have implications for a health-conscious lifestyle later in life and subsequently affect the risk of CAD.

Identifiants

pubmed: 31170283
pii: 5512096
doi: 10.1093/eurheartj/ehz328
pmc: PMC6669407
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2413-2420

Subventions

Organisme : British Heart Foundation
ID : RG/13/13/30194
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/14/5/30893
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/18/13/33946
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Références

Sci Rep. 2015 Nov 12;5:16509
pubmed: 26561353
Am Econ Rev. 2013 Oct;103(6):2087-120
pubmed: 29533059
Nat Genet. 2013 Nov;45(11):1274-1283
pubmed: 24097068
N Engl J Med. 2014 Nov 27;371(22):2072-82
pubmed: 25390462
Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):13366-13371
pubmed: 27799538
Nat Genet. 2010 May;42(5):441-7
pubmed: 20418890
Mol Psychiatry. 2016 Jun;21(6):758-67
pubmed: 27046643
Nat Genet. 2015 Oct;47(10):1121-1130
pubmed: 26343387
Proc Natl Acad Sci U S A. 2012 May 29;109(22):8461-6
pubmed: 22586112
J Clin Epidemiol. 2016 Jan;69:208-16
pubmed: 26291580
Mol Psychiatry. 2016 Oct;21(10):1477-82
pubmed: 26857597
Genet Epidemiol. 2013 Nov;37(7):658-65
pubmed: 24114802
Nat Genet. 2013 Jan;45(1):25-33
pubmed: 23202125
Nat Genet. 2009 Mar;41(3):334-41
pubmed: 19198609
Intelligence. 2014 Jan;42(100):83-88
pubmed: 24489417
Genet Epidemiol. 2016 May;40(4):304-14
pubmed: 27061298
Proc Natl Acad Sci U S A. 2012 May 22;109(21):8026-31
pubmed: 22566634
Proc R Soc Med. 1965 May;58:295-300
pubmed: 14283879
Merrill Palmer Q (Wayne State Univ Press). 2009 Jul;55(3):224-249
pubmed: 20390050
N Engl J Med. 2016 Dec 15;375(24):2349-2358
pubmed: 27959714
Eur Heart J. 2011 Jan;32(2):158-68
pubmed: 21088011
Psychol Sci. 2014 Nov;25(11):1975-86
pubmed: 25287667
Int J Epidemiol. 2016 Feb;45(1):178-85
pubmed: 26213105
N Engl J Med. 2007 Aug 2;357(5):443-53
pubmed: 17634449
Eur J Hum Genet. 2008 Oct;16(10):1164-72
pubmed: 18523454
Int J Epidemiol. 2015 Apr;44(2):512-25
pubmed: 26050253
J Epidemiol Community Health. 2011 Apr;65(4):301-9
pubmed: 20841371
Nat Genet. 2017 Sep;49(9):1385-1391
pubmed: 28714975
Nat Genet. 2018 Aug;50(8):1112-1121
pubmed: 30038396
Nature. 2016 May 11;533(7604):539-42
pubmed: 27225129
Nature. 2007 Jun 7;447(7145):661-78
pubmed: 17554300
Eur Heart J. 2014 Aug 1;35(29):1917-24
pubmed: 24917639
Nat Genet. 2009 Mar;41(3):280-2
pubmed: 19198612
JAMA. 2016 Apr 26;315(16):1750-66
pubmed: 27063997
Heart. 2016 Jun 15;102(12):958-65
pubmed: 26849899
PLoS Med. 2015 Mar 31;12(3):e1001779
pubmed: 25826379
Science. 2013 Jun 21;340(6139):1467-71
pubmed: 23722424
Health Econ. 2016 Mar;25(3):314-36
pubmed: 25581162
Nature. 2015 Feb 12;518(7538):197-206
pubmed: 25673413
Nat Rev Genet. 2013 Jul;14(7):507-15
pubmed: 23774735

Auteurs

Lingyao Zeng (L)

Deutsches Herzzentrum München, Klinik für Herz- und Kreislauferkrankungen, Technische Universität München, Lazarettstr. 36, Munich, Germany.

Ioanna Ntalla (I)

Department of Clinical Pharmacology, William Harvey Research Institute, Barts & The London Medical School, Queen Mary University of London, Charterhouse Square, London, UK.
Centre for Genomic Health, Queen Mary University of London, Charterhouse Square, London, UK.

Thorsten Kessler (T)

Deutsches Herzzentrum München, Klinik für Herz- und Kreislauferkrankungen, Technische Universität München, Lazarettstr. 36, Munich, Germany.
Deutsches Zentrum für Herz- und Kreislaufforschung (DZHK), Partner Site Munich Heart Alliance, Munich, Germany.

Adnan Kastrati (A)

Deutsches Herzzentrum München, Klinik für Herz- und Kreislauferkrankungen, Technische Universität München, Lazarettstr. 36, Munich, Germany.
Deutsches Zentrum für Herz- und Kreislaufforschung (DZHK), Partner Site Munich Heart Alliance, Munich, Germany.

Jeanette Erdmann (J)

Institute for Cardiogenetics and University Heart Center Luebeck, University of Lübeck, Maria-Goeppert-Straße 1, Lübeck, Germany.
DZHK (German Research Centre for Cardiovascular Research), Partner Site Hamburg/Lübeck/Kiel, Lübeck, Germany.

John Danesh (J)

Department of Public Health and Primary Care, MRC/BHF Cardiovascular Epidemiology Unit, University of Cambridge, Cambridge, UK.
Department of Public Health and Primary Care, NIHR Blood and Transplant Research Unit in Donor Health and Genomics, University of Cambridge, Cambridge, UK.
Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.

Hugh Watkins (H)

Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.

Nilesh J Samani (NJ)

Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.
National Institute for Health Research Leicester Cardiovascular Biomedical Research Centre, Leicester, UK.

Panos Deloukas (P)

Department of Clinical Pharmacology, William Harvey Research Institute, Barts & The London Medical School, Queen Mary University of London, Charterhouse Square, London, UK.
Centre for Genomic Health, Queen Mary University of London, Charterhouse Square, London, UK.
Princess Al-Jawhara Al-Brahim Centre of Excellence in Research of Hereditary Disorders (PACER-HD), King Abdulaziz University, Al-Malae'b St, Jeddah, Saudi Arabia.

Heribert Schunkert (H)

Deutsches Herzzentrum München, Klinik für Herz- und Kreislauferkrankungen, Technische Universität München, Lazarettstr. 36, Munich, Germany.
Deutsches Zentrum für Herz- und Kreislaufforschung (DZHK), Partner Site Munich Heart Alliance, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH